Our prior work revealed that osteosarcoma (OS) 143B cells secrete high S1P levels, and targeting the S1P-sphingomyelin pathway selectively impairs therapy-resistant, aggressive subpopulations within an acidic tumor niche, and it reduces xenograft tumor growth [15]. This evidence concerns the gene MBTPS1 and neoplasm.